Pharmesis International Ltd. announced unaudited consolidated earnings results for the first quarter ended March 31, 2016. For the period, the company reported revenue was RMB 14,313,000 against RMB 14,038,000 a year ago. Loss from operations was RMB 908,000 compared to RMB 746,000 a year ago. Loss before tax was RMB 1,059,000 against profit of RMB 151,000 a year ago. Loss attributable to equity holders of the company was RMB 1,096,000 against profit of RMB 296,000 a year ago. Diluted loss per share were 4.8 cents against earnings of 1.5 cents a year ago. Net cash flows used in operating activities was RMB 1,864,000 against net cash flows from operating activities of RMB 1,469,000 a year ago. Net cash flows used in operating activities due to its operating loss and cash used in its operations. Acquisition of property, plant and equipment was RMB 209,000 against RMB 4,000 a year ago. Net asset value per ordinary share was 4.13 cents compared to 4.18 cents a year ago.